According to Cointelegraph, global pharmaceutical giant Boehringer Ingelheim has partnered with Solve.Care, a blockchain-based healthcare platform. Solve.Care is planning to build a network backed by blockchain and digital assets to reliably share data about people with diabetes. The new healthcare system, known as the Diabetes Care Management Network, will be based on Solve.Care's blockchain platform. The network is designed to help coordinate patient care and share information about the risks, preventions, and symptoms associated with diabetes. It is reported that the German-based Boehringer is one of the 20 largest pharmaceutical companies in the world.